Article

Do you know what health complications can increase your risk of DVT?

Author(s):

In the Summer issue of CURE, the Side Note department focuses on deep vein thrombosis (DVT). This is a condition that occurs when a blood clot develops in a vein of the leg or pelvic region. Research has shown that at least half of all cancer patients suffer from DVT at some point. This side effect, which can be life-threatening, is often under diagnosed and undertreated. The best thing patients can do is being aware of the symptoms of DVT and informing their doctor when these symptoms arise. This Wednesday (June 16), the Coalition to Prevent DVT is hosting a webinar about this common cancer side effect. The webinar, "DVT: How Health Complications Can Increase Your Risk," will be Wednesday, June 16, at 12:30 p.m. ET, and led by Nancy Skinner, RN, CCM, of Riverside HealthCare Consulting. During the hour-long event, Skinner will cover what health complications increase your risk of DVT, how an individual can reduce that risk, and how to management techniques if DVT is already present. If interested, you can register for the webinar here.And make sure to check out the Summer issue of CURE for more about the causes, prevention, and management of DVT.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content